SEC Form 4 · accession 0001567619-18-001757
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giovani Twigge
Officer — CORPORATE VICE PRESIDENT
Period of report
Aug 21, 2018
Accepted (ET)
Aug 23, 2018 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2018 | M | 11,372 | $43.71 | A | 25,546 | D | |
| Common StockF2 | Aug 21, 2018 | S | 11,372 | $242.7077 | D | 14,174 | D | |
| Common Stock | Aug 23, 2018 | M | 2,286 | $43.71 | A | 16,460 | D | |
| Common Stock | Aug 23, 2018 | M | 2,180 | $45.84 | A | 18,640 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy)F6,F3 | $43.71 | Aug 21, 2018 | M | 11,372 | D | — | Feb 13, 2019 | Common Stock | 11,372 | 0 | D |
| Incentive Stock Option (right-to-buy)F6,F4 | $43.71 | Aug 23, 2018 | M | 2,286 | D | — | Feb 13, 2019 | Common Stock | 2,286 | 0 | D |
| Incentive Stock Option (right-to-buy)F6,F5 | $45.84 | Aug 23, 2018 | M | 2,180 | D | — | Feb 13, 2020 | Common Stock | 2,180 | 0 | D |
Explanation of responses
- F1Includes 24 shares shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2018
- F2Represents the weighted average sales price of the shares sold ranging from a low of $242.51 to a high of $243.25 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Grant of option to buy 7,394 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2013, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F4Grant of option to buy 1,143 shares of Issuer common stock that vested in one installment on February 14, 2017, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F5Grant of option to buy 1,090 shares of Issuer common stock that vested in one installment on February 14, 2018, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F6Not applicable.